全文获取类型
收费全文 | 836篇 |
免费 | 50篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 12篇 |
妇产科学 | 8篇 |
基础医学 | 132篇 |
口腔科学 | 7篇 |
临床医学 | 79篇 |
内科学 | 191篇 |
皮肤病学 | 3篇 |
神经病学 | 71篇 |
特种医学 | 50篇 |
外科学 | 124篇 |
综合类 | 13篇 |
预防医学 | 78篇 |
眼科学 | 8篇 |
药学 | 57篇 |
中国医学 | 4篇 |
肿瘤学 | 61篇 |
出版年
2023年 | 6篇 |
2022年 | 37篇 |
2021年 | 42篇 |
2020年 | 22篇 |
2019年 | 29篇 |
2018年 | 33篇 |
2017年 | 11篇 |
2016年 | 26篇 |
2015年 | 22篇 |
2014年 | 41篇 |
2013年 | 49篇 |
2012年 | 71篇 |
2011年 | 80篇 |
2010年 | 38篇 |
2009年 | 43篇 |
2008年 | 47篇 |
2007年 | 47篇 |
2006年 | 48篇 |
2005年 | 38篇 |
2004年 | 39篇 |
2003年 | 38篇 |
2002年 | 49篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 5篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 3篇 |
1993年 | 5篇 |
1992年 | 4篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1983年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有908条查询结果,搜索用时 15 毫秒
101.
Flix Blanc-Durand Marie Florescu Mustapha Tehfe Bertrand Routy Raafat Alameddine Danh Tran-Thanh Normand Blais 《Current oncology (Toronto, Ont.)》2021,28(2):1045
Background: Epidermal growth factor receptor (EGFR) is the most common oncogenic mutation in lung adenocarcinoma and tyrosine kinase inhibitors (TKIs) have been considered standard treatment for more than a decade. However, time to initiation of TKIs (TTIT) from diagnosis is often delayed and represents a challenge for clinicians. We aimed to assess the impact of TTIT on clinical outcomes and complications. Method: TTIT was defined as the time between confirmed advanced diagnosis and the initiation of a TKI. Complications during this pre-TKI period were retrospectively collected from all patients with EGFR-mutant non small cell lung cancer (NSCLC) in our institution. Results: 102 patients were diagnosed with EGFR mutated NSCLC between 2006 and 2019. The median PFS and OS were 12.9 and 22.5 months, respectively. TTIT was 5.7 months (95% CI 3.4–8) with a significant decrease in the latter years of this cohort. During the pre-TKI period, 23 patients received chemotherapy as first line treatment, of which 5 developed severe adverse events and 3 were not fit to receive TKI thereafter. Additionally, 29 patients had rapid clinical deterioration before initiation of first line TKI and 16 had to be hospitalized. Among the patients presenting a performance status deterioration, their prognosis was markedly affected compared to the remainder of the cohort (p = 0.01). Conclusion: Our real-world evidence study supports the concept that a delay to treat EGFR mutant NSCLC with TKIs is associated with adverse events, patient progression, hospitalization, and decreased overall survival. Rapid molecular diagnosis, including access to ctDNA technology may circumvent these deleterious delays. 相似文献
102.
Hoedemaekers CW Ezzahti M Gerritsen A van der Hoeven JG 《Critical care (London, England)》2007,11(4):R91
Background
Temperature management is used with increased frequency as a tool to mitigate neurological injury. Although frequently used, little is known about the optimal cooling methods for inducing and maintaining controlled normo- and hypothermia in the intensive care unit (ICU). In this study we compared the efficacy of several commercially available cooling devices for temperature management in ICU patients with various types of neurological injury. 相似文献103.
Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy 总被引:6,自引:0,他引:6
Vigouroux C Maachi M Nguyên TH Coussieu C Gharakhanian S Funahashi T Matsuzawa Y Shimomura I Rozenbaum W Capeau J Bastard JP 《AIDS (London, England)》2003,17(10):1503-1511
OBJECTIVES: Adipocytokines, secreted by adipose tissue, may regulate fat metabolism, lipid and glucose homeostasis and insulin sensitivity. We analysed the relations between circulating concentrations of adiponectin, leptin, interleukin-6, tumor necrosis factor alpha and its soluble receptors sTNFR1 and R2, lipodystrophic phenotypes and metabolic alterations in patients under highly active antiretroviral therapy (HAART). METHODS: We studied 131 consecutive HIV-infected males under protease inhibitor (PI)-based HAART, with body mass index < 27 kg/m2 and C-reactive protein (CRP) < 10 mg/l. Patients were classified in four groups according to clinical examination: no lipodystrophy (NL), lipohypertrophy (LH), lipoatrophy (LA) and mixed lipodystrophy (ML). In addition to adipocytokines, we measured plasma fasting levels of triglycerides, cholesterol, cardiovascular risk markers (high-sensitivity CRP and apolipoproteins B/A1 ratio), fasted and 2 h post-glucose loading glycemia and insulinemia and calculated the quantitative insulin sensitivity check index. RESULTS: The patients were HIV-infected and PI-treated for a mean of 8.2 and 1.6 years respectively; 74% presented lipodystrophy, 38% altered glucose tolerance and 42% hypertriglyceridemia. Insulin sensitivity correlated positively with adiponectin and negatively with leptin and interleukin-6. Adiponectin, but not leptin, negatively correlated with all metabolic parameters. Insulin resistance, metabolic defects and cardiovascular risk markers were strongly negatively correlated with the adiponectin/leptin ratio (A/L), and positively with sTNFR1. LA patients had a longer duration of infection but ML patients presented the most severe metabolic alterations, insulin resistance and A/L decrease. CONCLUSIONS: These results suggest that adiponectin and the TNFalpha system are related to lipodystrophy, insulin resistance and metabolic alterations in patients under PI-based HAART. A/L and sTNFR1 could predict insulin sensitivity and potential cardiovascular risk in these patients. 相似文献
104.
Jean Marc Regimbeau David Fuks Patrick Pessaux Philippe Bachellier Denis Chatelain Momar Diouf Artigas Raventos Georges Mantion Jean-Francois Gigot Laurence Chiche Gerard Pascal Daniel Azoulay Alexis Laurent Christian Letoublon Emmanuel Boleslawski Michel Rivoire Jean-Yves Mabrut Mustapha Adham Yves-Patrice Le Treut Jean-Robert Delpero Francis Navarro Ahmet Ayav Karim Boudjema Gennaro Nuzzo Michel Scotte Olivier Farges 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(1):79-86
Introduction
As mortality and morbidity after a curative resection remains high, it is essential to identify pre-operative factors associated with an early death after a major resection.Methods
Between 1998 and 2008, we selected a population of 331 patients having undergone a major hepatectomy including segment I with a lymphadenectomy and a common bile duct resection for a proven hilar cholangiocarcinoma in 21 tertiary centres. The study''s objective was to identify pre-operative predictors of early death (<12 months) after a resection.Results
The study cohort consisted of 221 men and 110 women, with a median age of 61 years (range: 24–85). The post-operative mortality and morbidity rates were 8.2% and 61%, respectively. The 1-, 3- and 5-year overall survival rates were 85%, 64% and 53%, respectively. The median tumour size was 23 mm on pathology, ranging from 8 to 40. A tumour size >30 mm [odds ratio (OR) 2.471 (95% confidence interval (CI) 1.136–7.339), P = 0.001] and major post-operative complication [OR 3.369 (95% CI 1.038–10.938), P = 0.004] were independently associated with death <12 months in a multivariate analysis.Conclusion
The present analysis of a series of 331 patients with hilar cholangiocarcinoma showed that tumour size >30 mm was independently associated with death <12 months. 相似文献105.
Nicolas Javaud Jallal Achamlal Paul-George Reuter Frédéric Lapostolle Akim Lekouara Mustapha Youssef Lilia Hamza Ahmed Karami Frédéric Adnet Olivier Fain 《Medicine》2015,94(45)
The number of cases of acquired angioedema related to angiotensin converting enzyme inhibitors induced (ACEI-AAE) is on the increase, with a potential concomitant increase in life-threatening attacks of laryngeal edema. Our objective was to determine the main characteristics of ACEI-AAE attacks and, in doing so, the factors associated with likelihood of hospital admission from the emergency department (ED) after a visit for an attack.A prospective, multicenter, observational study (April 2012–December 2014) was conducted in EDs of 4 French hospitals in collaboration with emergency services (SAMU 93) and a reference center for bradykinin-mediated angioedema. For each patient presenting with an attack, emergency physicians collected demographic and clinical presentation data, treatments, and clinical course. They recorded time intervals from symptom onset to ED arrival and to treatment decision, from ED arrival to specific treatment with plasma-derived C1-inhibitor (C1-INH) or icatibant, and from specific treatment to onset of symptom relief. Attacks requiring hospital admission were compared with those not requiring admission.Sixty-two eligible patients with ACEI-AAE (56% men, median age 63 years) were included. Symptom relief occurred significantly earlier in patients receiving specific treatment than in untreated patients (0.5 [0.5–1.0] versus 3.9 [2.5–7.0] hours; P < 0.0001). Even though icatibant was injected more promptly than plasma-derived C1-INH, there, however, was no significant difference in median time to onset of symptom relief between the 2 drugs (0.5 [0.5–1.3] versus 0.5 [0.4–1.0] hours for C1-INH and icatibant, respectively, P = 0.49). Of the 62 patients, 27 (44%) were admitted to hospital from the ED. In multivariate analysis, laryngeal involvement and progressive swelling at ED arrival were independently associated with admission (Odds ratio [95% confidence interval] = 6.2 [1.3–28.2] and 5.9 [1.3–26.5], respectively). A favorable course was observed in all patients. Three patients (5%) experienced a recurrence after angiotensin-converting enzyme inhibitor discontinuation after a median follow-up of 18 (11–30) months.Two severity criteria—laryngeal edema and the progression of the edema—were independent factors associated with likelihood of hospital admission. Appropriate specific treatments (plasma-derived C1-INH or icatibant) should be available in EDs to prevent possibly life-threatening complications. 相似文献
106.
107.
108.
Frederick K. Korley MD PhD Steven P. Schulman MD Lori J. Sokoll PhD Andrew P. DeFilippis MD MSc Andrew I. Stolbach MD Jamil D. Bayram MD MPH MEd Mustapha O. Saheed MD Rodney Omron MD MPH Christopher Fernandez Albert Lwin Stephen S. Cai Wendy S. Post MD Allan S. Jaffe MD 《Academic emergency medicine》2014,21(7):727-735
109.
110.